Assignee
KINASE PHARMA INC
CA·3 granted patents·1 pending application·1 citations·filing 2018–2023
Top patents by PatentIndex Score
4 records- 0186US11603541B2Compositions and method of making a complex able to increase production of a cetuximab-like protein (CLP) in a target cellKINASE PHARMA INC·Filed 2021·Granted Mar 14, 2023·1 cites·4 claims
- 0278US12325864B2Recombinant virus vector (RVV) for inhibiting epidermal growth factor receptor (EGFR) activity and method of making an agent/target cell complex to increase cetuximab-like protein (CLP) productionKINASE PHARMA INC·Filed 2023·Granted Jun 10, 2025·0 cites·5 claims
- 0359US11793889B2Methods for selective kinase inhibition by endogenously produced antagonists of one or more kinasesKINASE PHARMA INC·Filed 2018·Granted Oct 24, 2023·0 cites·4 claims
- 0457US2022267795A1Compositions and methods for regulating production of an angiogensis inhibitorKINASE PHARMA INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KINASE PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →